| Today's Big NewsMay 4, 2023 |
| By Annalee Armstrong The KRAS inhibitor scene has always been a bit braggadocious with Amgen and Mirati Therapeutics battling it out for the first-to-market advantage. But now a new crop of scrappy KRAS upstarts has arrived on the medical conference circuit, trying to needle away at the leaders. |
|
|
|
By Annalee Armstrong The headline number from Eli Lilly’s Alzheimer’s data showing a 36% slowing of cognitive decline may have grabbed eyes, but analysts see a more even comparison with Biogen and Eisai’s Leqembi when you dig a little deeper. |
By James Waldron Three years after the FDA forced Novo Nordisk to pause a trial of its potential Hemlibra rival over reports of blood clots, the U.S. regulator has placed a further barrier in front of the drug—even as it secures approval in other territories. |
By Nick Paul Taylor Roche is betting preclinical drug development is on the cusp of a major change. After tracking advances in fields including engineering and computational science, the Swiss drugmaker has set up the Institute of Human Biology (IHB) and asked its staff to collaborate with external partners to create better models. |
By Annalee Armstrong Pfizer and Valneva are pushing back a regulatory filing for their Lyme disease vaccine by a year after the companies were forced to pull half of the participants from a phase 3 study in February. |
By Nick Paul Taylor Lackluster midphase efficacy data have pushed Ionis Pharmaceuticals to trim its pipeline. The antisense specialist tossed out acromegaly prospect cimdelirsen and abandoned hopes of developing sapablursen in beta thalassemia. |
By Gabrielle Masson After sending mice into space, researchers have discovered that blocking or removing certain proteins can prevent muscle and bone loss—findings that could potentially translate into new therapies for humans with various conditions back here on Earth. |
By Zoey Becker GSK is basking in "the golden age" of vaccine development with its newest shot, an exec said. Its next step will be to turn the recent approval into actual vaccinations, Leonard Friedland, M.D., vice president and director of scientific affairs and public health at GSK vaccines, said in an interview. |
By Andrea Park Though it’s currently cleared by the FDA to lessen ADHD symptoms only in children between the ages of 8 and 12, Akili Interactive’s EndeavorRx digital therapeutic may actually be even more effective among older users. |
By Dave Muoio Kaufman Hall reports healthier hospital operations in March but warned that underlying labor and acuity trends are still worth keeping an eye on. |
By Joseph Keenan ValGenesis, which manages digital validation and approval processes for CROs, is teaming up with Dubai-based Mepharma to provide a wider service offering for drug development and clinical trial sites in the Middle East and North Africa. |
By Joseph Keenan Syneos Health, a North Carolina-based CRO, has tapped Michael Bonello as its next chief financial officer, effective July 1. |
Fierce podcastsDon't miss an episode |
| | This week on "Podnosis," we discuss how the healthcare industry is addressing its role in climate change. |
|
|---|
|
|
|
July 18-19, 2023 | Jersey City, NJ
Connect with senior PR and communications leaders from big pharma, small-mid size pharma, biotech and more to gain insights and best practices on daily challenges in the industry. Save $500 when you Register Today!
|
|
| eBookDiscover a game-changing approach to clinical research with Hybrid and Decentralized Clinical Trials (DCTs). Learn about the benefits, challenges, and key elements for success. Sponsored by: EvidentIQ |
| Research What role do the Library and Legal teams play in the drug development pipeline at Lilly? An import one – find out how. Sponsored by: CCC |
| WhitepaperThis paper focuses on stakeholder engagement and how Medical Affairs teams’ responsibilities, goals, tools, and techniques are changing. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| ResearchStrategies for Optimal Site Selection and Feasibility Research in Novel Therapies and Geographies Sponsored by: H1 |
| Whitepaper How can eConsent provide a more flexible approach to informed consent? Sponsored by: YPrime |
| Whitepaper Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
| WhitepaperExplore how clinical supply can be scaled up as decentralized programs progress, and how technological solutions can accelerate trial deployment. Sponsored by: Catalent Clinical Supply |
| Whitepaper As sponsors increasingly look to CROs to support their clinical studies, making and addressing certain clinical supply considerations at the outset of the relationship can reduce the risk of potentially unforeseen impact to budget and time later. Discover key issues sponsors should consider to help their CRO or partner of choice better understand their clinical supply needs. Sponsored by: Catalent |
| WhitepaperFor sponsors, cost is a key concern when it comes to managing the supply of their clinical trials. A financial project analyst (FPA) is a specialized expert who can help control clinical supply costs and keep the project within budget. Explore the critical role that a Financial Project Analyst plays in clinical trial supply and budget management. Sponsored by: Catalent |
| WhitepaperLearn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
| WhitepaperDiscover key considerations that every trial sponsor should know when navigating the complex clinical supply distribution landscape across Asia-Pacific. Sponsored by: Catalent |
| WhitepaperHow can specialized expertise help you optimize your clinical supply chain? Learn about the roles and responsibilities of unique experts such as clinical supply management, project management, and financial project analysis. Sponsored by: Catalent Clinical Supply |
| WhitepaperExplore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
| WhitepaperPlanning on using a CRO to support your next clinical study? This infographic outlines critical areas to address at the start of the relationship in order to ensure that budget and timelines keep on track for the duration of the trial. Sponsored by: Catalent |
| |
|
